Personalized therapy for lung cancer: striking a moving targetSuchita Pakkala, Suresh S. Ramalingam|JCI Insight|2018Cited by 147
Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancerTaofeek K. Owonikoko, Fadlo R. Khuri, Suchita Pakkala et al.|Journal of Translational Medicine|2016Cited by 89
Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II studySuchita Pakkala, Taofeek K. Owonikoko, Kristin Higgins et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 67
Investigating the Molecular Profile of Lung Adenocarcinoma: A Single-Institution AnalysisConor Steuer, Suresh S. Ramalingam, Madhusmita Behera et al.|International Journal of Radiation Oncology*Biology*Physics|2014Cited by 0